Robert E. Landry - 27 Mar 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Robert E. Landry
Issuer symbol
REGN
Transactions as of
27 Mar 2023
Net transactions value
-$1,841,829
Form type
4
Filing time
29 Mar 2023, 16:07:07 UTC
Previous filing
07 Feb 2023
Next filing
25 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $305,536 +800 +2.5% $381.92 32,905 27 Mar 2023 Direct F1
transaction REGN Common Stock Tax liability $486,025 -589 -1.8% $825.17 32,316 27 Mar 2023 Direct F1
transaction REGN Common Stock Options Exercise $1,136,940 +3,000 +9.3% $378.98 35,316 27 Mar 2023 Direct F1
transaction REGN Common Stock Tax liability $1,818,675 -2,204 -6.2% $825.17 33,112 27 Mar 2023 Direct F1
transaction REGN Common Stock Sale $31,959 -39 -0.12% $819.47 33,073 27 Mar 2023 Direct F1, F2
transaction REGN Common Stock Sale $41,023 -50 -0.15% $820.46 33,023 27 Mar 2023 Direct F1, F3
transaction REGN Common Stock Sale $39,427 -48 -0.15% $821.39 32,975 27 Mar 2023 Direct F1, F4
transaction REGN Common Stock Sale $14,806 -18 -0.05% $822.57 32,957 27 Mar 2023 Direct F1, F5
transaction REGN Common Stock Sale $3,297 -4 -0.01% $824.30 32,953 27 Mar 2023 Direct F1
transaction REGN Common Stock Sale $10,733 -13 -0.04% $825.59 32,940 27 Mar 2023 Direct F1
transaction REGN Common Stock Sale $3,317 -4 -0.01% $829.16 32,936 27 Mar 2023 Direct F1
transaction REGN Common Stock Sale $5,810 -7 -0.02% $830.01 32,929 27 Mar 2023 Direct F1
transaction REGN Common Stock Sale $8,188 -10 -0.03% $818.81 32,919 28 Mar 2023 Direct F1
transaction REGN Common Stock Sale $94,398 -115 -0.35% $820.85 32,804 28 Mar 2023 Direct F1, F6
transaction REGN Common Stock Sale $116,639 -142 -0.43% $821.40 32,662 28 Mar 2023 Direct F1, F7
transaction REGN Common Stock Sale $105,302 -128 -0.39% $822.67 32,534 28 Mar 2023 Direct F1, F8
transaction REGN Common Stock Sale $149,072 -181 -0.56% $823.60 32,353 28 Mar 2023 Direct F1, F9
transaction REGN Common Stock Sale $129,453 -157 -0.49% $824.54 32,196 28 Mar 2023 Direct F1, F10
transaction REGN Common Stock Sale $200,565 -243 -0.75% $825.37 31,953 28 Mar 2023 Direct F1, F11
transaction REGN Common Stock Sale $25,617 -31 -0.1% $826.36 31,922 28 Mar 2023 Direct F1
holding REGN Common Stock 250 27 Mar 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,000 -13% $0.000000 20,337 27 Mar 2023 Common Stock 3,000 $378.98 Direct F1, F12
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -800 -100% $0.000000* 0 27 Mar 2023 Common Stock 800 $381.92 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.
F2 Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F9 Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F10 Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F11 Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F12 The stock option award vests in four equal annual installments, commencing one year after the date of grant.